Skip to content

LivaNova LIVN Work in process

Work in process at other companies

Abbott logo
AbbottABT
$994M+11.7%
Haemonetics logo
HaemoneticsHAE
$17.5M-45.5%
ITG
Integer HoldingsITGR
$157.03M+16.9%
Medtronic logo
MedtronicMDT
ResMed logo
ResMedRMD
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's work in process?
LivaNova (LIVN) reported work in process of $18.1M in Q1 2026.
How has LivaNova's work in process changed year-over-year?
LivaNova's work in process increased by 19.4% year-over-year, from $15.16M to $18.1M.
What is the long-term trend for LivaNova's work in process?
Over 5 years (2020 to 2025), LivaNova's work in process has grown at a 9.8% compound annual growth rate (CAGR), from $8.06M to $12.88M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.